Recently, numerous studies have implicated the JAK2/STAT3 signaling pathway in the progression of DN and various diabetic characters such as hyperglycemia, angiotensin II, and AGEs can also activate the JAK/STAT pathway. The gene discussed is JAK2; the disease is liver dysplastic nodule.